Nexium Control Uses, Dosage, Side Effects and more
Nexium Control is under investigation in clinical trial NCT03416491 (Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C).
| Trade Name | Nexium Control |
| Generic | Coblopasvir |
| Coblopasvir Other Names | Coblopasvir |
| Type | Capsules |
| Formula | C41H50N8O8 |
| Weight | Average: 782.899 Monoisotopic: 782.375160602 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | GlaxoSmithKline Consumer Healthcare |
| Available Country | United Kingdom, Netherlands |
| Last Updated: | January 7, 2025 at 1:49 am |
